Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
41 /100
MEDIUM RISK
Score updated Aug 28, 2026

INMB — INmune Bio Inc. Dilution Risk Tracker

Track INMB dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track INMB — Get alerts when the score changes →

As of August 28, 2026, INmune Bio Inc. (INMB) has a DilutionWatch DilutionScore of 41/100, rated MEDIUM dilution risk. INmune Bio Inc. has a market capitalization of $37.49M, 27.75M shares outstanding, 82 institutional holders tracked. Stored dilution-related fields include 1.56M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
46
💰 Cash Runway
40
📊 Float Risk
25
⚠️ Warrant Exposure
30
🔄 Convertible Debt
40

Dilution Forecast

Watch
Minor dilution signals detected
model est. 19%
🔄 Reverse Split model est. 30%
• 50-day avg $1.36 approaching $1 threshold
📜 Warrant Exercise model 15%
• Warrant overhang: 5.6% of shares outstanding
🔔 Track INMB — Get forecast alerts →

Market Data

Market Cap$37.49M
Shares Outstanding27.75M
Float22.16M
Cash$24.75M
Debt$12.19M
Short InterestN/A

Institutional Holdings

QoQ: ↑ 24.2% shares (2026Q1 vs prior)
82 institutional holders · 6.57M shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 1.37M shares
#2 BlackRock, Inc. 1.19M shares
#3 GEODE CAPITAL MANAGEMENT, LLC 495.0K shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest2.20M
Days to Cover6.6
% of Float9.9%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2025-12-31
xbrl XBRL CONVERTIBLE 2017-12-31
Full SEC filing analysis available with free account

Recent News

No recent news

Factual INMB Dilution Snapshot

INmune Bio Inc. (INMB) has a DilutionScore of 41/100, rated Medium dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track INMB Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking INMB — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for INMB
INMB FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.